Vaping-Induced Acute Respiratory Distress Syndrome (ARDS): A Clinical Case Study in Functional Recovery

2020 ◽  
Vol 74 (4_Supplement_1) ◽  
pp. 7411515368p1
Author(s):  
Malachy Clancy ◽  
Sara Steinagel ◽  
Fiona Egan
Author(s):  
Duncan McLean ◽  
Matthias Eikermann

This chapter provides a summary of the landmark study known as Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome. Do neuromuscular blocking agents (NMBs) improve outcomes in patients with acute respiratory distress syndrome who are receiving mechanical ventilation? Starting with that question, the chapter describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism, and limitations. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case. The study found that patients with severe ARDS may benefit from short-term NMB infusions with certain caveats, as noted in the chapter.


2009 ◽  
Vol 102 (11) ◽  
pp. 1150-1157 ◽  
Author(s):  
James C. Jackson ◽  
Ramona O. Hopkins ◽  
Russell R. Miller ◽  
Sharon M. Gordon ◽  
Arthur P. Wheeler ◽  
...  

2021 ◽  
Vol 9 (40) ◽  
pp. 74-76
Author(s):  
Mohamed Bahi ◽  
Younes Aissaoui ◽  
Ayoub Belhadj ◽  
Youssef Qamouss ◽  
Rachid Seddiki

Acquired neuromuscular weakness often develops in patients with an acute respiratory distress syndrome (ARDS), in particular in patients who are ventilated and sedated for long periods. This has been rarely described in the literature on ARDS secondary to SARS-CoV-2 infection. Our clinical case revealed the existence of these neuromuscular manifestations in the COVID-19 disease after the use of hydroxyzine, an antihistamine whose respiratory side-effects are unknown. Keywords: Neuromuscular weakness, COVID-19, hydroxyzine, hypercapnia.


2021 ◽  
pp. 68-73
Author(s):  
O. Golubovska ◽  
O. Gudzenko ◽  
A. Zaplotna ◽  
I. Shestakova ◽  
O. Bezrodna ◽  
...  

The clinical case of imported falciparum malaria is described in the article. The diagnosis was confirmed on the 6-th day of the disease when cerebral presentations manifested. The course of the disease was severe and it was characterized by serious complications due to late diagnosis and starting of treatment: malaria coma, malaria alhid, acute respiratory distress syndrome, nozocomial pneumonia, acute renal failure, malaria hepatitis, severe hemolytic anemia. The patient recovered. Presentations of severe anemia progressed after plasmodium disappearance in the blood and persisted after discharge of patient from the hospital.


2001 ◽  
Vol 29 (3) ◽  
pp. 562-566 ◽  
Author(s):  
Ganesh Suntharalingam, FRCA ◽  
Kate Regan ◽  
Brian F. Keogh, FRCA ◽  
Clifford J. Morgan, FRCA ◽  
Timothy W. Evans

Sign in / Sign up

Export Citation Format

Share Document